Business · 09/10/2026Updated: 10/15/2026 · 1 min read
Par Health USA LLC, U.S. Agent for PH Health Limited, et al.; Withdrawal of Approval of 37 Abbreviated New Drug Applications
Summary
The FDA is withdrawing approval of 37 abbreviated new drug applications from multiple applicants, following written notifications from the applicants.
Original source language: Federal Register — Health and Human ServicesOpen original release →